One Biosciences

French tech company | Builders Republic

About

Precision-oncology biotech spun out of Institut Curie that turns single-cell tumor analysis into treatment guidance — its OneMap platform profiles each patient's tumor cell by cell to map drug-resistant and aggressive cell populations, helping oncologists stratify patients, guide therapy choice and de-risk drug development.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series A
Founded
2020
City
PARIS
Region
IDF
Tracked rounds
2
Amount raised
22 M€ raised since 2020

Funding rounds

  • Series A — 2025
  • Series A — 2022

Investors